Emerging drugs for the treatment of uveitis.

  title={Emerging drugs for the treatment of uveitis.},
  author={Theresa G Leung and Jennifer E. Thorne},
  journal={Expert opinion on emerging drugs},
  volume={18 4},
INTRODUCTION Uveitis is a potentially visually debilitating disease when untreated or poorly controlled. Chronic intermediate, posterior, or panuveitis often requires systemic immunosuppressive therapy to prevent such visual loss. AREAS COVERED This review discusses existing treatments for ocular inflammation including corticosteroids, antimetabolites, alkylating agents, T-cell inhibitors, and biologic agents. Potential drugs being studied in clinical trials are introducing new routes for… CONTINUE READING
4 Citations
61 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 61 references

Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to noninfectious uveitis

  • CM Deuter, I K€otter, I Günaydin
  • Br J Ophthalmol
  • 2009
Highly Influential
5 Excerpts

Long-term Clinical Outcomes in Patients with Refractory Uveitis Associated with Behçet Disease Treated with Infliximab

  • S Al Rashidi, A Al Fawaz, D Kangave, AM. Abu El-Asrar
  • Ocul Immunol Inflamm 2013;epub
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…